批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/11/28 |
SUPPL-29(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/09/25 |
SUPPL-31(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2017/08/04 |
SUPPL-26(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2015/11/05 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/06/25 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2012/10/31 |
SUPPL-21(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2012/02/28 |
SUPPL-19(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2011/06/17 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/06/12 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/04/10 |
SUPPL-11(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2006/04/10 |
SUPPL-10(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2006/03/22 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/01/05 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/05/27 |
SUPPL-5(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2002/09/06 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/02/11 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/09/25 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/09/24 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/10/06 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:FLUVASTATIN SODIUM 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:EQ 80MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021192 |
001 |
NDA |
LESCOL XL |
FLUVASTATIN SODIUM |
TABLET, EXTENDED RELEASE;ORAL |
EQ 80MG BASE |
Prescription |
Yes |
Yes |
AB |
2000/10/06
|
SANDOZ |
079011 |
001 |
ANDA |
FLUVASTATIN SODIUM |
FLUVASTATIN SODIUM |
TABLET, EXTENDED RELEASE;ORAL |
EQ 80MG BASE |
Prescription |
No |
No |
AB |
2016/01/27
|
TEVA PHARMS USA |
209397 |
001 |
ANDA |
FLUVASTATIN SODIUM |
FLUVASTATIN SODIUM |
TABLET, EXTENDED RELEASE;ORAL |
EQ 80MG BASE |
Prescription |
No |
No |
AB |
2021/04/26
|
BEIJING |